1. Home
  2. IGC vs BTCT Comparison

IGC vs BTCT Comparison

Compare IGC & BTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
    SELLHOLDBUYas of a day ago
  • BTCT
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • IGC 2005
  • BTCT 2006
  • Country
  • IGC United States
  • BTCT China
  • Employees
  • IGC N/A
  • BTCT N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • BTCT Other Consumer Services
  • Sector
  • IGC Health Care
  • BTCT Real Estate
  • Exchange
  • IGC Nasdaq
  • BTCT Nasdaq
  • Market Cap
  • IGC 29.4M
  • BTCT 28.3M
  • IPO Year
  • IGC N/A
  • BTCT N/A
  • Fundamental
  • Price
  • IGC $0.31
  • BTCT $5.28
  • Analyst Decision
  • IGC Strong Buy
  • BTCT
  • Analyst Count
  • IGC 2
  • BTCT 0
  • Target Price
  • IGC $3.75
  • BTCT N/A
  • AVG Volume (30 Days)
  • IGC 369.7K
  • BTCT 5.5M
  • Earning Date
  • IGC 02-25-2025
  • BTCT 02-19-2025
  • Dividend Yield
  • IGC N/A
  • BTCT N/A
  • EPS Growth
  • IGC N/A
  • BTCT N/A
  • EPS
  • IGC N/A
  • BTCT N/A
  • Revenue
  • IGC $1,183,000.00
  • BTCT $8,482,000.00
  • Revenue This Year
  • IGC N/A
  • BTCT $11.07
  • Revenue Next Year
  • IGC $13.38
  • BTCT $5.27
  • P/E Ratio
  • IGC N/A
  • BTCT N/A
  • Revenue Growth
  • IGC N/A
  • BTCT N/A
  • 52 Week Low
  • IGC $0.27
  • BTCT $1.32
  • 52 Week High
  • IGC $0.91
  • BTCT $26.58
  • Technical
  • Relative Strength Index (RSI)
  • IGC 42.69
  • BTCT 43.81
  • Support Level
  • IGC $0.29
  • BTCT $4.94
  • Resistance Level
  • IGC $0.33
  • BTCT $5.58
  • Average True Range (ATR)
  • IGC 0.01
  • BTCT 0.58
  • MACD
  • IGC 0.00
  • BTCT -0.05
  • Stochastic Oscillator
  • IGC 43.20
  • BTCT 15.32

Stock Price Comparison Chart: IGC vs BTCT

IGC
BTCT
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober202505101520253035404550556065IGC VS BTCT

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

About BTCT BTC Digital Ltd.

BTC Digital Ltd is a crypto asset technology company based in the U.S. with a focus on bitcoin mining. The company also generates revenue through mining machine resale and rental business operations.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use